Pablo Andrés Caviedes Fernández
Full professor
PROGRAMA DE FARMACOLOGÍA MOLECULAR Y CLÍNICA, ICBM, FAC. DE MEDICINA, U. DE CHILE
Santiago, Chile
CERAMIC NANOMATERIALS; HYBRID NANOCOMPOSITE BIOMATERIALS; mecanisms of neurodegeneration ; Down syndrome, cell therapy, stem cell differentiation, tissue microencapsulation; Modification of Natural Polymers Biomimetic; Bio-related Materials;
-
Medical Doctor, UNIVERSIDAD DE CHILE. Chile, 1986
-
Biomedical Sciences, UNIVERSIDAD DE CHILE. Chile, 1998
-
Visiting Fellow Full Time
NATIONAL INSTITUTE OF HEALTH
Natl. Institute on Aging
Bethesda, MD, Estados Unidos
1986 - 1989
-
Visiting Associate Full Time
national institutes of health
National Institue on Diabetes, Digestive and Kidney Diseases
Bethesda, MD, Estados Unidos
1989 - 1991
-
Investigador Asociado Full Time
Centro de Estudios CIentificos de Santiago
Santiago, Chile
1991 - 1992
-
Professor Full Time
UNIVERSIDAD DE CHILE
Medicine
Santiago, Chile
1992 - A la fecha
-
Senior researcher Part Time
Sansum Diabetes Research Institute
Santa Barbara, CA, Estados Unidos
2000 - 2003
-
Profesor Titular Part Time
UNIVERSIDAD DE CHILE
Facultad de Ciencias Física y Matemáticas
Santiago, Chile
2020 - A la fecha
-
Profesor Titular Part Time
Tip: Search for English results only. You can specify your search language in Preferences Instituto Milenio de Dinámica Celular y BiotecnologíaTip: Search for English results only. You can specify your search language in Preferences Instituto Milenio de
Ssantiago, Chile
2019 - A la fecha
-
Visiting Fellow Full Time
National Institutes of Heath
Bethesda, MD, Estados Unidos
1986 - 1989
-
Visiting Associate Full Time
National Institutes of Heath
Bethesda, MD, Chile
1989 - 1991
-
Associate researcher Full Time
Centro de Estudios Cientificos de Santiago
Snatiago, Chile
1991 - 1992
-
Senior Researcher Part Time
Sansum Diabetes Research Institute
Santa Barbara, CA, Estados Unidos
2000 - 2003
-
Professor Full Time
University of Chile
Santiago, Chile
1992 - A la fecha
-
Profesor Titular Part Time
Instituto Milenio de Dinámica Celular y Biotecnología (ICDB)
Santiago, Chile
2019 - A la fecha
Thesis directed (2007 – present. 15 prior to 2007)
1.- Ongoing:
- Christian Arriagada. PhD Thesis, PhD program in Biomedical Sciences, Fac. of Medicine, Univ. of Chile. Autophagy in neuronal cell lines established from a mouse model of Down syndrome
- Claudia Jara Cancino. Thesis Director, PhD in Pharmacology, Faculty of Chemistry & Pharmacy, Univ. of Chile. Microencapsulation of spherical cell aggregates of ? and ? cells, differentiated from human adipose tissue derived mesenchymal stem cells.
- Natalia Barraza Thesis Director, PhD in Pharmacology, Faculty of Chemistry & Pharmacy, Univ. of Chile.. Eff of overexpressed APP on PAK activity sand actin filament ploymerization in a celular model of Down symdrome
- Belén Gaete, Thesis Director, Bs degree in Biochemstry, Pontificial Catholic Univ. of Valparaíso, Chile.. Phamacological modulation of P21- Activated kinases (PAK) in an in vitro neuronal model of Down syndrome: Consequnces on process growth and branching.
2.- Finished
- Ramón Pérez Nuñez. Thesis Director, Thesis Director, PhD in Biochemistry, Faculty of Chemistry & Pharmacy, Univ. of Chile.. Effect of DSCAM overexpression on morphological parameters in cell models of Down síndrome: the role of the P21- Activated kinases (PAK) pathway. Possible examination date: August 2016
Esteban González. PhD Thesis, PhD program in Medical Sciences, Fac. of Medicine, Univ. of Chile. Differentiation of human stem and mesenchimal cells into myocardiocytes: Application to cell transplant in ischemic heart disease. Exam: June 15, 2016
- Paulina Salazar. Thesis Director, MsC in Genetics, Faculty of Medicine, Univ . de Chile. Study of nFATC4 activity in a neuronal cell line derived from a murine model of Down syndrome Exam: June 27, 2015.
- Nicolás Pereira. Thesis Director, MsC in Molec & Cellular Biomedicine, Faculty of Medicine, Univ . de Chile. Effects od differnt cryopreservation media on adipose-derived stem cell viability: Which is the best cryporeservative? Exam: June 30, 2015.
- Ximena Cataldo Thesis Director, MsC in Nutrition, Faculty of Medicine, Univ . de Chile. Neuroprotection induce by ?-cryptoxanthine in a neuronal cell line derived from the cerebral cortex of a trisomy 16 mouse, and animal model for Down syndrome. Exam: November 3 2014
- Natalia Galarce Toro. Bs degree in Chemical Engineering, Univ.of Chile. Effect of ion release on cell viability in polymeric composites bearing copper nanoparticles. Exam: Dicembe 2013.
- Macarena Beltrán Carpentier. Bs degree in Chemical Engineering, Univ.of Chile. Study on the biocompatibility of plymeric composites bearing coppr nanoparticles. Exam: June 2013.
- Natalia Barraza: Contribution of DSCR1 to tau protein hyperphosphorilation in trisomy 21. MsC in Biological Sci, major in Neuroscience. U. Valparaíso (Co tutor, A.M. Cárdenas). Exam: July 2013
Mario Acuña. Msc Thesis codirector (with C. Arriagada). Effect of RCAN1 overexpression on Ca2+ currents in a cell line derived from the cerebral cortex of a trisomy 16 mouse; an animal un model of Down Syndrome. Fac. Of Sciences. U. of Chile. Exam: January 2012.
- Jura Mikkola. Thesis director, MSc in Neuroscience. University of Jyväskylä, Finland. Effect of Sod1 and Sod1/APP knockdown in cholinergic dysfunction in a neuronal cell line derved from the cerebral cortex of a trisomy 16 mouse, an animal model of Down syndrome. Exam: July 2008.
- Adriana Armijo. Thesis director, MSc in Neuroscience, Faculty of Medicine, Univ. of Chile. Characterization of a cell line derived from the primary motor cortex off an adult rat: A model for cell transplant therapy in rats submitted to cerebral ischemia. Exam: March 2008
- Patricio Cabané Toledo. Thesis director, PhD in Medical Sciences, Faculty of Medicine, Univ. of Chile. Optimization of culture conditions for parathyroid cells: Use in cell transplant therapy in hypoparathyroidism. Exam: January 2008
- Ignacio Díaz Franulic. Thesis director, Degree in Biochemistry, University of Chile. Effect of Slc5a3 (SMIT1, myo-inositol cotransporter) knockdown in cholinergic dysfunction of a cell line derived from the brain of a trisomy 16 mouse, an animal model of Down syndrome. Exam: December, 2007.
- Paola Fernández Olivares. Thesis codirector (with A.M. Cárdenas), Degree in Biochemistry, Catholic University of Valparaiso. Effect of Slc5a3 (SMIT1, myo-inositol cotransporter) knockdown in Ca2+ signaling in a cell line derived from the brain of a trisomy 16 mouse, an animal model of Down syndrome. Exam: June 29, 2007.
Tutorships, Research Units: Rodrigo Carrasco (PhD Program in Medical Sciences, Fac. of Medicine,, Univ. of Chile , 2007). Rodrigo Nieto (PhD Program in Medical Sciences, Fac. of Medicine,, Univ. of Chile , 2007). Dario Vázquez (PhD Program in Medical Sciences, Fac. of Medicine,, Univ. of Chile , 2007). Jorge Noriega(PhD Program in Biomedical Sciences, Fac. of Medicine,, Univ. of Chile , 2009). Mario Acuña (MsC Program, Faculty of Science, Univ. de Chile., 2010)
Teaching, graduate courses:
-Professor, Graduate course, Introduction to Neuroscience, Fac. of Medicine, Univ. de Chile. 2007- present.
-Professor, Graduate course, Systems physiology. Fac. of Medicine, Univ. de Chile. 2007- present.
-Professor, Graduate course,, Physical activity Physiology. Fac. of Medicine, Univ. de Chile. 2007- 2009.
-Professor & coordinator, Internacional course: “Molecular & Cellular Mechanisms of Neuronal Damage. Therapeutical approaches”. March 23 - 25, 2007 (Pucón, Chile), and April 23 -26 de Abril, 2009 (Arica, Chile)
- Professor, MsC program Biological Sciences, Univ. of Valparaíso (2007). Topic:: “Cellular and trophic factor therapy in neurodegenerative pathology”
Bibliographic seminars, mechanisms of neurodegenerative pathology (Coord. Claudio Hetz) (2009 – 2010)
Member PhD in Pharmacology , Committee, Faculty of medicine and Faculty of Chemistry & Pharmacy, Fac of Medicine, Univ of Chile. Since January 2014.
PAPERS PRIOR TO 1995:
- Fiedler, J., Rapoport, S.I., Epstein, C.J., Caviedes, R. and Caviedes, P. Altered cholinergic function in cultured neurons from the trisomy 16 mouse fetus, a model for Down Syndrome. Brain Res., 658 (1994), 27-32.
- Caviedes, P., Caviedes, R., Liberona, J.L. and Jaimovich, E. Ion currents in a skeletal muscle cell line from a Duchenne muscular dystrophy patient. Muscle & Nerve. 17 (1994), 1021-1028.
- Vargas, F. F., Caviedes, P. and Grant, D. S.. Electrophysiological characteristics of cultured human umbilical vein endothelial cells. Microvasc. Res. 47 (1994), 153-165.
- Caviedes, P., Olivares, E., Salas, K., Caviedes, R. and Jaimovich, E.. Calcium fluxes, ion currents and dihydropyridine receptors in a newly established cell line from rat heart muscle. J. Molec. & Cell Cardiol. (1993), 25 (1993), 829-845.
- Caviedes, P., Koistinaho, J., Ault, B. and Rapoport, S. I.. Effects of nerve growth factor on the electrical membrane properties of cultured dorsal root ganglia neurons from normal and trisomy 21 human fetuses. Brain Res., 556 (1991), 285-291.
- Caviedes, P., Ault, B. and Rapoport, S. I.. A replated culture preparation improves whole cell voltage clamp conditions of human fetal sensory neurons. J. Neurosci. Meth., 35 (1990), 57-61.
- Caviedes, P., Ault, B. and Rapoport, S. I.. Electrical membrane properties of cultured dorsal root ganglion neurons from trisomy 19 mouse fetuses: a comparison with the trisomy 16 mouse fetus, a model for Down syndrome. Brain Res., 511 (1990) 169-172.
- Caviedes, P., Ault, B. and Rapoport, S. I.. The role of altered sodium currents in the action potential abnormalities of cultured dorsal root ganglion neurons from trisomy 21 (Down syndrome) human fetuses. Brain Res., 510 (1990) 229-236.
- Ault, B., Caviedes, P., Hidalgo, J., Epstein, C.J. and Rapoport, S. I.. Electrophysiological analysis of cultured fetal mouse dorsal root ganglion neurons transgenic for human superoxide dismutase-1, a gene in the obligate Down syndrome region of chromosome 21. Brain Res., 497 (1989) 191-194.
- Ault, B., Caviedes, P. and Rapoport, S. I.. Neurophysiological abnormalities in cultured dorsal root ganglion neurons from the trisomy 16 mouse fetus, a model for Down Syndrome. Brain Res., 485 (1989) 165-170.
PATENTS
1.- Freeman, TB, Caviedes, P., Caviedes, R. Conditioned medium and Proliferated Cell Lines Produced Therefrom. Pub US 2008/0175828 A1, Date: Dec 25, 2012. US Patent No US 8.337.829 B2..
2.- Freeman, TB, Caviedes, P., Caviedes, R. Proliferated Cell Lines and Uses Thereof. Japanese patent number 4.741.189. Filed Feb 7, 2003. Granting date: May 13, 2011.
3.- Caviedes, P., Caviedes, R., Freeman, TB, Asenjo, J., Andrews, B., Sepúlveda, D, Arriagada, C. y Salazar Rivera, J.. Materials and Methods for Regulating Process Formation in Cell Culture. US Patent, Letters, US 7.323.333 B2, Date: Jan 29, 2008. Pub. US Patent No 8,252,279, 8 Agosto 2012.
4.- Caviedes, P., Caviedes, R., Freeman TB, Sanberg, PR., Cameron DF. Proliferated Cell Lines and Uses Thereof. Canada Application No 2.476.214. Filed 2/7/2003, number pending.
5.- Cameron, DF, Caviedes, P., Caviedes R., Freeman, TB, Sanberg, PR. Proliferated cell Lines and uses thereof. Europe application EP 157524 (A2). Pub Date Sept 21, 2005. Number pending.
-
Conicyt PhD Fellowship
conicyt
Chile, 1991
National Fellowship to carry out a PhD program
Microencapsulation of Parathyroid Cells for the Treatment of Hypoparathyroidism |
Cellular and tissue microencapsulation for cellular therapy |
The price of development in chile: Overcoming environmental hazards produced by heavy industrial exploitation |
Methods for cell therapy |
Materials and Methods for Regulating Process Formation in Cell Culture |
Ketogenic diet ameliorates dysferlinopathy phenotype by promoting mitochondrial function in in vitro and in vivo models of the disease. |
Adquisición de un sistema de biorreactor para el escalamiento de la producción de biomasa y compuestos de interés biotecnológico a partir de células animales en cultivo |
Escalamiento en la producción de células mesenquimales derivadas de tejido humano adiposo para su diferenciación a células productoras de Insulina y glucagon |
Role of dysferlin in cytoskeletal actin remodeling and its impact on vesicle trafficking and membrane repair in muscular dystrophy linked to dysferlin mutations |
ROLE OF DYSFERLIN IN CYTOSKELETAL ACTIN REMODELING AND ITS IMPACT ON VESICLE TRAFFICKING AND MEMBRANE REPAIR IN MUSCULAR DYSTROPHY LINKED TO DYSFERLIN MUTATIONS. |
Further insights on the study of limb girdle muscular dystrophies (LGMD) in the Chilean population: Linking genetic mutation, epidemiology, and cellular mechanisms of the disease |
FURTHER INSIGHTS ON THE STUDY OF LIMB GIRDLE MUSCULAR DYSTROPHIES (LGMD) IN THE CHILEAN POPULATION=> LINKING GENETIC MUTATION, EPIDEMIOLOGY, AND CELLULAR MECHANISMS OF THE DISEASE. |
Equipo de prototipado rapido para producción de scaffolds mediante diseño asistido por computadora: 3D bioplotter |
Adquisición de un microscopio electrónico de barrido y equipos auxiliares (sem-edx) para investigación avanzada en ciencias odontológicas |
La actividad física acelera la progresión del daño muscular en modelos animales de disferlinopatías: Posible papel de los hemicanales. |
Role of overexpressed DSCAM and APP in PAK kinase derregulation, and the consequent neuronal dysfunction in invitro models of Down syndrome=> A quest for cellular therapeutical targets. |
Synthesis and evaluation of bioactive nanocomposites based on ceramic nanoparticles and polymers for bone tissue engineering in dentistry |
Molecular and cellular mechanisms of muscular dystrophy related to en mutations of dysferlin |
Molecular and cellular mechanisms of muscular dystrophy related to mutations of dysferlin |
Studies on degeneration mechanism of dopaminergic neurons induced by aminochrome and polymorphism prevalence in Chilean Parkinson's patients. |
Role of Dyrk1a and Dscr1 overexpression in genetic regulatory circuits and cellular dysfunction of immortalized neuronal cells derived from the trisomy 16 mouse, an animal model of human Down syndrome=> Possible therapeutic targets. |
Non-enzymatic isolation of viable islets by differential osmotic shock. |
Vectores adenovirales para la terapia génica en el tratamiento del alcoholismo |
Estudio de Mercado de los Ensayos Clínicos en Chile, en Fases I, II, III y IV |
Estudios acerca del mecanismo molecular de la enfermedad de Parkinson=> Posible papel neuroprotector de DT-diaforasa y GST M2-2 en cultivos celulares y asociacion de coexistencia de polimorfismos de DT-diaforasa y alfa-sinucleina con E.de Parkinson. |
Purification and Characterization of a Transformation Factor Secreted by a Rat Thyroid Tumor Cell Line. |
Estudios químicos, farmacológicos y toxicológicos de Haplopappus multifolius y H. taeda, conducentes al desarrollo de una Monografía del "bailahuén". |
Gene dosage effects in cholinergic and glutamatergic dysfunction of immortalized neuronal cells derived from the trisomy 16 mouse, an animal model of human Down syndrome. |
GENE DOSAGE EFFECTS IN CHOLINERGIC AND GLUTAMATERGIC DYSFUNCTION OF IMMORTALIZED NEURONAL CELLS DERIVED FROM THE TRISOMY 16 MOUSE, AN ANIMAL MODEL OF HUMAN DOWN SYNDROME |
Rol de genes relacionados con el sindrome de Down en las alteraciones del calcio intracelular en una línea neuronal derivada de corteza cerebral de ratón trisómico 16, modelo animal de la condición humana. Intercambio CNRS/Conicyt . |
Modèles cellulaires du syndrome de Down humain => Rôle de la Surexpression génique dans le mauvais fonctionnement neuronal de cellules immortalisées de système nerveux de la souris trisomique 16. |
Estudios acerca del mecanismo de toxicidad de o-quinonas derivadas de dopamina y el posible polimorfismo de DT-diaforasa y GST M-2 / M1-1 en enfermos de Parkinson chilenos. |
Establishment of a human substantia nigra cell line for use in cell transplant therapy of Parkinson’s disease. |
Evaluación de líneas celulares inmortales para transplante celular en el tratamiento de la enfermedad de Parkinson experimental en monos parkinsonizados con MPTP. |
Mecanismos de neurotoxicidad y neuroproteccion en modelos animales y celulares de Parkinson. ECOS/Conicyt |
LINEAS CELULARES IMPORTANTEAS DERIVADAS DEL SISTEMA NERVIOS RATON CON TRISOMIA 16, MODELO DE LA TRISOMIA 21 HUMANA=>POSIBLES MODELOS FISIOPATOLOGICOS |
Líneas celulares inmortales derivadas de sistema nervioso del ratón con trisomía 16, modelo animal de la trisomía 21 humana=> Posibles modelos fisiopatológicos. |
MECANISMOS DE ACOPLAMIENTO ENTRE EXCITACION Y TRANSCRIPCION EN CELULAS DE MUSCULO ESQUELETICO |
Mecanismos de acoplamiento entre excitación y transcripción en células de músculo esquelético |
Señales de Ca2+ en tejido neuronal. , INSERM/Conicyt, Intercambio Chile- Francia |
Calcium regulation in nerve and muscle cells. |
PARTICIPACION DEL IGF-I EN LA GENESIS Y DESARROLLO DE LA HIPERTROFIA CARDIACA PATOLOGICA EXPERIMENTAL=> ESTUDIO Y MODULACION FARMACOLOGICA DE SUS MECANISMOS DE TRANSDUCCION |
Un modelo celular del Sindrome de Down para evaluar las alteraciones de las propiedades eléctricas de la membrana celular en neuronas=> Establecimiento y caracterización de líneas celulares inmortales a partir de tejido neuronal. |
Caracterización de líneas celulares humanas de músculo esquelético normal y distrófico. |
celulares humanas de músculo esquelético normal y distrófico. |
Estudio de actividad eléctrica en el ratón con trisomía 16, modelo animal para la trisomía 21 humana (Sindrome de Down). |
Estudio de actividad eléctrica y secreción de sustancias vasoactivas en endotelio en cultivo |